Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Yohei Chiba

4PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|May 13, 2026
Comparative Effectiveness of Bevacizumab and Olaparib Maintenance Therapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Real-World Study with Exploratory Evaluation of Dose Reduction.

|Jan 22, 2026
Peripheral blood lymphocyte and eosinophil dynamics with chemotherapy and pembrolizumab in cervical cancer.

Sho Sato, Masahiro Kagabu, Ami Jo

|Jul 27, 2024
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer.

Sho Sato, Tadahiro Shoji, Ami Jo

|Jan 22, 2024
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.

Yohei Chiba, Masahiro Kagabu, Mitsumasa Osakabe

Pageof 1

Frequent Collaborators

3 joint publications

Sho Sato

3 joint publications

Tadahiro Shoji

3 joint publications

Tsukasa Baba

2 joint publications

Masahiro Kagabu

1 joint publications

Takayuki Nagasawa

Frequent Collaborators

3 joint publications

Sho Sato

3 joint publications

Tadahiro Shoji

3 joint publications

Tsukasa Baba

2 joint publications

Masahiro Kagabu